Daewoong Pharmaceutical Co. Ltd.
Clinical trials sponsored by Daewoong Pharmaceutical Co. Ltd., explained in plain language.
-
New study tests apremilast to tame psoriasis Flare-Ups
Disease control Not yet recruitingThis study tests a drug called apremilast in 425 adults with moderate-to-severe psoriasis that has lasted at least 6 months. Participants take the tablet for 32 weeks to see if it improves skin symptoms like redness and scaling. The goal is to manage the condition, not cure it, s…
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Could a simple nasal device stop COVID and flu?
Prevention Not yet recruitingThis study tests whether using two nasal protective devices together can lower the chance of getting respiratory infections like COVID-19 and the flu. About 2000 adults will use the devices in daily life for 8 weeks. The study also checks how easy they are to use and if they caus…
Phase: NA • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Prevention
Last updated Apr 29, 2026 15:05 UTC
-
New obesity drug candidate passes first safety check in healthy people
Knowledge-focused Not yet recruitingThis early-stage study tests whether a new drug called DWRX5003 is safe in healthy adults. It also measures how the drug moves through the body compared to two other versions. The goal is to gather safety data, not to treat any disease. About 72 healthy volunteers aged 19 to 65 w…
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC